APSR2026-934

 
Late-Breaking
Submitted
Oral Presentation
AO32-004
 
 
https://storage.unitedwebnetwork.com/files/1285/1242059-46903-APSR26_Oral 934-V1_434235.pptx
Format: PPTX Only
 
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
7

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Dezhu Tang * Chongqing Emergency Medical Center Department of Respiratory Medicine Chongqing China the First Affiliated Hospital of Chongqing Medical University Department of Respiratory and Critical Care Medicine Chongqing China
Tingting Tingting - the First Affiliated Hospital of Chongqing Medical University Department of Respiratory and Critical Care Medicine Chongqing China Mianyang 404 Hospital Pulmonary and Critical Care Medicine Mianyang China
Ting He - the People’s Hospital of Yubei District Department of Respiratory and Critical Care Medicine Chongqing China
Zhiping Xu - The Fifth People's Hospital of Chongqing Department of Respiratory and Critical Care Medicine Chongqing China
Li Zhang - Daping Hospital of Army Medical University Department of Respiratory Medicine Chongqing China
Weiwei Shu - Yongchuan Hospital of Chongqing Medical University Department of Critical Care Medicine Chongqing China
Li Peng - the First Affiliated Hospital of Chongqing Medical University Department of Respiratory and Critical Care Medicine Chongqing China
 
 
 
 
 
 
 
 
Presenting Author Details
Dezhu
Tang
315049929@qq.com
+8618375984626
31-40
China
Original Research
Pneumocystis jirovecii Pneumonia in Non-HIV Immunosuppressed Patients: Disease-Specific Risk Heterogeneity and Independent Predictors from a Multicenter Cohort Study
Maximum 25 words
Abstract Content
The risk of Pneumocystis jirovecii pneumonia (PCP) in non-HIV immunosuppressed patients and its variation by underlying disease remain poorly characterized, hindering targeted prophylaxis. To delineate the incidence spectrum of PCP and identify independent risk factors in this population.
This multicenter retrospective cohort study included 962 non-HIV immunosuppressed patients from seven Chinese hospitals (2015–2022). The primary outcome was incident PCP. Multivariable Cox regression was used to identify independent risk factors.
Overall PCP incidence was 4.16% (40/962), with substantial variation across disease subgroups. The highest incidence was observed in kidney transplant recipients (29.03%, 9/31), followed by acute lymphoblastic leukemia (ALL) without hematopoietic stem cell transplant (HSCT) (25.00%, 4/16) and post-HSCT acute myeloid leukemia (AML) (12.77%, 6/47). No PCP cases occurred in patients with systemic lupus erythematosus (0/138) or multiple myeloma (0/139). Multivariable Cox analysis identified ALL without HSCT (adjusted hazard ratio [aHR]=20.06, 95%CI:6.58–61.11), kidney transplantation (aHR=15.50, 95%CI:6.50–36.98), diffuse large B-cell lymphoma without HSCT (aHR=5.64, 95%CI:2.36–13.45), and post-HSCT AML (aHR=8.18, 95%CI:3.14–21.29) as independent risk factors (all P<0.001).
PCP risk varies markedly by underlying disease. ALL without HSCT, kidney transplantation, DLBCL without HSCT, and post-HSCT AML define high-risk populations, supporting disease-based risk stratification over universal prophylaxis.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Pneumocystis jirovecii pneumonia; non-HIV; risk factors
maximum 3 keywords and no abbreviations, separated by commas
Not Applicable
233